The Collaborators
Accelerating Cancer Cures is supported by leading biopharmaceutical companies who are committed to finding new cures for cancer. The charter participants are: Eli Lilly and Company, Ariad, Celgene, Genentech, Merck, Millennium: The Takeda Oncology Company, Pfizer, and The Pharmaceutical Research and Manufacturers of America (PhRMA). Competitors in the marketplace, these companies have a shared belief that funding young physician-scientists with a commitment to innovation in cancer research will have a profound impact on the next generation of cancer breakthroughs.
